CorVista Health

CorVista Health is an innovative diagnostics company tackling the high rates of misdiagnosis in cardiovascular disease through a proprietary, non-invasive point-of-care platform. By fusing data science with disease biology, the company's technology analyzes subtle physiologic changes to flag risks for multiple conditions simultaneously, aiming to provide answers during a routine doctor's visit. Recent data presentations at major cardiology conferences indicate active clinical validation of its lead test for detecting coronary artery disease, including challenging cases like ischemia with no obstructive coronary arteries (INOCA). As a private, likely pre-revenue company, CorVista is positioning itself to address a massive unmet need in frontline cardiovascular diagnostics.

A non-invasive, point-of-care diagnostic platform that fuses data science and machine learning with disease biology. It analyzes subtle physiologic changes, autonomic patterns, systemic stress, and vascular dynamics to detect multiple cardiovascular conditions simultaneously from a single assessment.

CorVista competes with traditional diagnostic methods (stress tests, imaging, invasive angiography) and a growing field of digital health and AI-driven diagnostic companies. Its differentiation lies in its specific focus on point-of-care, multi-condition analysis for challenging cardiovascular diagnoses like INOCA, where current options are limited.